Muscle Increase & Fat Loss Women Cycle

**4 x Ultima-Bold** - Ultima Pharmaceuticals [10 ml x 250 mg/ml]
**8 x Ultima-Win** - Ultima Pharmaceuticals [10 ml x 50 mg/ml]
**2 x Ultima-Clen-Salbuto** - Ultima Pharmaceuticals [50 pills x 2 mg]
**1 x Ultima-Nolva** - Ultima Pharmaceuticals [50 pills x 20 mg]

MANUFACTURER Ultima Pharmaceuticals - Cycles
WAREHOUSE International Warehouse 3
SUBSTANCE Boldenone Undecylenate, Stanozolol Suspension, Tamoxifen Citrate, Salbutamol

Brand: Ultima Pharmaceuticals

14-Week Muscle Gain & Fat Loss Cycle for Women by Ultima Pharmaceuticals. This expertly crafted stack is your go-to solution for achieving impressive muscle gains while promoting effective fat loss. Designed for both efficiency and affordability, this combination ensures you can enjoy significant bulking and fat-burning benefits without breaking the bank. What sets this cycle apart is its focus on potent anabolic steroids that minimize common androgenic side effects like hair loss and acne. Ultima-Win helps lower SHBG levels while moderately aromatizing Boldenone, making this cycle particularly beginner-friendly. Experience enhanced muscle pumps, improved vascularity, and a gradual increase in lean muscle mass. With Equipoise?s slow-release anabolic properties, this cycle avoids water retention, instead delivering sustained energy and endurance. The inclusion of Stanozolol aids in reducing excess fluid, ensuring your muscles appear defined and firm. Following a high-calorie diet, users can anticipate gaining up to 6 kg of quality muscle while shedding fat, with post-cycle therapy allowing athletes to retain up to 80% of their hard-earned gains.

- **Ultima-Bold**: 200 mg every other day - **Ultima-Win**: 30-40 mg per day - **Post Cycle Therapy (PCT)**: Ultima-Clen-Salbuto and Ultima-Nolva

Dosage:

Please note that our recommendations are based on personal experiences and should not be considered professional advice. We encourage you to consult a healthcare professional for tailored guidance.

OSGear disclaims any responsibility for issues arising from product misuse or the results obtained during the cycle.